Inventor · disambiguated record
Nathalie Vergnolle
Also filed as: VERGNOLLE NATHALIE
4 granted patents·4 pending applications·3 citations·filing 2010–2021
62Inventor score
Top patents by PatentIndex Score
8 records- 0165US9125861B2PAR2 agonists for use in the treatment or prevention of influenza virus type A infectionsVERGNOLLE NATHALIE·Filed 2010·Granted Sep 8, 2015·2 cites·13 claims
- 0264US9688742B2Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)INST NAT SANTE RECH MED·Filed 2014·Granted Jun 27, 2017·1 cites·6 claims
- 0357US11692045B2Method of treating inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) or gluten hypersensitivity by administering an elastase 2A (ELA2A) inhibitorINST NAT SANTE RECH MED·Filed 2020·Granted Jul 4, 2023·0 cites·4 claims
- 0450US10829563B2Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitorINST NAT SANTE RECH MED·Filed 2017·Granted Nov 10, 2020·0 cites·8 claims
- 0547US2013344033A1Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)INST NAT SANTE RECH MED·Filed 2013·Application pending·0 cites
- 0645US2023340149A1Methods of treatment of inflammatory bowel diseasesINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0739US2022340881A1Method for Differentiating Epithelial Stem CellsUrosphere·Filed 2020·Application pending·0 cites
- 0838US2012195859A1Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)VERGNOLLE NATHALIE·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →